Tag: Noxopharm
Noxopharm doses first patient in NOXCOVID-1 clinical trial with Veyonda
Australian drug development company Noxopharm has dosed the first patient in the phase 1 NOXCOVID-1 clinical trial with Veyonda, its lead pipeline candidate, in hospitalized ... Read More
Noxopharm launches NOXCOVID-1 clinical trial of Veyonda across Europe
Noxopharm, an Australian clinical-stage pharma company, has started the phase 1 NOXCOVID-1 clinical trial for Veyonda in Europe to evaluate the anti-cancer drug candidate as ... Read More